BRCA mutation rate and characteristics of prostate tumor in breast and ovarian cancer families: analysis of 6,591 Italian pedigrees.
Laura CortesiFederica DomatiAnnalisa GuidaIsabella MarchiAngela TossElena BarbieriLuigi MarcheselliMarta VenturelliSimonetta PianaClaudia CirilliMassimo FedericoPublished in: Cancer biology & medicine (2021)
It appears the Modena criteria are very useful for BRCA testing selection in families with breast and/or ovarian cancer and PrC. A trend toward a worse prognosis has been found in BRCA2 carriers.